Business

Markets jump, Dow futures upload greater than 1,400 issues after upbeat vaccine information, Biden victory

Stock futures surged Monday morning as traders took in promising data on a leading COVID-19 vaccine candidate as well as President-elect Joe Biden’s victory in the U.S. presidential election, ending a days-long nail-biter over which candidate would prevail in winning the White House.

Contracts on the Dow jumped more than 1,400 points, or about 5%, setting the index up to extend its sharp gains from last week. Contracts on the S&P 500 jumped more than 3%, while those on the Nasdaq lagged as traders turned away from the software stocks and other tech names that had comprised the “stay-at-home” trade.”

Shares of Pfizer (PFE) jumped more than 12% in pre-market trading after the company announced that their clinical trial showed that their vaccine candidate was more than 90% effective in preventing COVID-19 in participants with no evidence of a previous coronavirus infection. Shares of BioNTech (BNTX), which is working on the vaccine alongside Pfizer, jumped more than 14% higher during the early session.

Biden, alongside Vice President-elect Kamala Harris, is set to usher in a push for bigger fiscal stimulus, a public option in health care, investment in sustainability, and a more measured approach to foreign policy and trade, among other key issues. And in his victory speech Saturday, Biden promised to work toward these goals with an eye toward uniting a deeply divided nation, calling for an end of “this grim era of demonization in America” and underscoring that “if we can decide not to cooperate, then we can decide to cooperate.”

So far, traders have cast bets that some of the suspected “market negative” potential of a Biden presidency, such as a move to raise corporate taxes, would be tempered by a Senate that remained under Republican control. Two Senate races remain outstanding in Georgia and will not be decided until January, though prediction markets have so far given Democrats relatively slim odds of winning both seats needed for the party to claim a majority in the chamber.

“A divided government would constrain the Biden administration’s ability to implement plans for large-scale fiscal stimulus and public investment, tax, healthcare and climate related legislation,” analysts from BlackRock Investment Institute said in a note Saturday. “We see an increased focus on sustainability under a divided government, but through regulatory actions, rather than via tax policy or spending on green infrastructure. It also would likely signify a return to more predictable trade and foreign policy – even as U.S.-China rivalry is set to stay elevated due to bipartisan support for a more competitive stance.”

The analysts added that “some fiscal stimulus looks possible” during the lame-duck session in Congress, though the size and scope of any forthcoming package is likely to be much smaller than what a united Democratic government might have advanced.

“We’re monitoring the fiscal response closely, as a premature retrenchment could set back an economic restart that has so far surprised to the upside,” they said.

Other economists also expressed optimism that a stimulus package might get passed ahead of Inauguration Day, even after the months’ worth of discussions between Trump administration officials and congressional lawmakers fizzled out without an agreement.

“We are becoming increasingly hopeful that pressure from business leaders and vulnerable Republican Senators in 2022 will mean that something can pass before the end of the year, and very preferably before the end of the month,” Ian Shepherdson, chief economist for Pantheon Macroeconomics, said in a note Sunday.

Meanwhile, for the high-flying tech stocks that have driven the market higher for much of this year, a Biden presidential victory with a likely Republican Senate poses the “goldilocks Election outcome,” according to WedBush analyst Dan Ives.

“Investors should expect a ratcheting down of US/China tensions and the ‘decoupling path’ of the Cold Tech war, which is a bullish sign for Apple (AAPL) and semi [semiconductor] stocks looking ahead,” Ives said in a note Saturday. Concerns of a tougher antitrust environment for Big Tech companies have also likely eased, he added.

Biden is also set to strike a more serious tone on combatting the coronavirus pandemic, with the outbreak having already taken the lives of more than 230,000 Americans, sickened more than 9.8 million and dragged U.S. economic activity to a historic nadir. And while vote counts were under way last week, coronavirus cases hit a grim milestone in the United States: A record more than 120,000 new cases reported on Friday alone. Biden is set to announce a new 12-person coronavirus task force on Monday, as one of his first major acts during his presidential transition, according to reports from Axios and CNN.

7:16 a.m. ET Monday: Dow futures surge more than 1,400 points after upbeat vaccine data, Biden victory

Here were the main moves in equity markets, as of 7:16 a.m. ET:

  • S&P 500 futures (ES=F): 3,629.40, up 119.5 points or 3.4%

  • Dow futures (YM=F): 29,737.00, up 1,456 points or 5.15%

  • Nasdaq 100 futures (NQ=F): 12,144.25, up 98.25 points or 0.8%

7:10 a.m. ET Monday: Pfizer, BioNTech, say their COVID-19 vaccine candidate is more than 90% effective

Shares of Pfizer and German drug-maker BioNTech each soared Monday morning after the companies announced that their Phase 3 clinical trials showed their COVID-19 vaccine candidate was more than 90% effective in preventing the coronavirus in participants with no evidence of a previous infection.

The trial’s analysis assessed 94 confirmed COVID-19 infections among nearly 44,000 participants.

“The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90%, at 7 days after the second dose,” the companies said in a statement. “This means that protection is achieved 28 days after the initiation of the vaccination, which consists of a 2-dose schedule.”

The companies added that they planned to submit a request for Emergency Use Authorization of their vaccine candidate to the U.S. Food and Drug Administration after they have a total of two months’ worth of data to achieve the agency’s safety requirements. This is expected to take place in the third week of November.

6:01 p.m. ET Sunday: Stock futures open higher after Biden named winner of presidential election

Here were the main moves in markets, as of 6:01 p.m. ET Sunday evening:

  • S&P 500 futures (ES=F): 3,517.00, up 16.25 points or 0.46%

  • Dow futures (YM=F): 28,334.00, up 130 points or 0.46%

  • Nasdaq futures (NQ=F): 12,141.5, up 66.5 points or 0.55%

Wilmington, PennsylvaniaNov. 7, 2020President-elect Joe Biden addresses supporters at Chase Center in Wilmington, DE, on Nov, 7, 2020 after being named the winners. (Carolyn Cole / Los Angeles Times via Getty Images)
Wilmington, PennsylvaniaNov. 7, 2020President-elect Joe Biden addresses supporters at Chase Center in Wilmington, DE, on Nov, 7, 2020 after being named the winners. (Carolyn Cole / Los Angeles Times via Getty Images)

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and reddit.

Find live stock market quotes and the latest business and finance news

For tutorials and information on investing and trading stocks, check out Cashay


Read More: https://www.kbcchannel.tv | For More Business Articles | Visit Our Facebook & Twitter @kbcchanneltv | Making The Invisible, Visible


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker
%d bloggers like this: